Carbamazepine induces mitotic arrest in mammalian Vero cells

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 637, Issue 1-2, 2008, Pages 124-133

  Perez Martin J M ^a   Fernandez Freire P ^a   Labrador, V ^a   Hazen, M J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Apoptosis; Carbamazepine; Mitotic arrest; Monopolar spindle; Vero cells

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CENTROSOME; CONTROLLED STUDY; DRUG CYTOTOXICITY; METAPHASE; MITOSIS INDEX; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

ANIMALS; APOPTOSIS; CARBAMAZEPINE; CELL CYCLE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; MITOSIS; MITOTIC SPINDLE APPARATUS;

MAMMALIA;

EID: 37149017381     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.07.014     Document Type: Article

References (67)

1. Beghi E., and Carbamazepine. Clinical efficacy and use in other neurologic disorders. In: Levy R., Mattson R., Meldrum B., and Perucca E. (Eds). Antiepileptic Drugs (2002), Lippincott Williams & Wilkins, Philadelphia 273-277
2. McNamara J. Drugs effective in the therapy of the epilepsies. In: Hardman J., and Limbird L. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (2001), McGraw-Hill, New York
3. Trimble M., and Carbamazepine. Clinical efficacy and use in psychiatic disorders. In: Levy R., Mattson R., Meldrum B., and Perucca E. (Eds). Antiepileptic Drugs (2002), Lippincott Williams & Wilkins, Philadelphia 278-284
4. Ambrósio A., Soares-da-Silva P., Carvalho C., and Carvalho A. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem. Res. 27 (2002) 121-130
5. Macdonald R. Carbamazepine. Mechanism of action. In: Levy R., Mattson R., Meldrum B., and Perucca E. (Eds). Antiepileptic Drugs (2002), Lippincott Williams & Wilkins, Philadelphia 227-235
6. Fischer M., Hamm H., and Wirbelauer J. Severe drug-related skin reaction: toxic epidermal necrolysis caused by carbamazepine. Klin. Padiatr. 216 (2004) 288-293
7. Lin M.S., Dai Y.S., Pwu R.F., Chen Y.H., and Chang N.C. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern. Med. J. 35 (2005) 188-190
8. Kalapos M. Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation. Adverse Drug React. Toxicol. Rev. 21 (2002) 123-141
9. Grieco A., Alfei B., Di Rocco P., Miele L., Biolcati G., Griso D., Vecchio F., Bianco A., and Gasbarrini G. Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. Eur. J. Gastroenterol. Hepatol. 13 (2001) 973-975
10. Gorrel J. Management of pediatric epilepsy syndromes. US Pharmacol. (2002) 75-84
11. Hagarty J., Picton M., Agarwal G., Pramanik A., and Kalra P. Carbamazepine-induced acute granulomatous interstitial nephritis. Clin. Nephrol. 57 (2002) 310-313
12. König S., Knolle J., Friedewald S., Koelfen W., Longin E., Lenz T., and Hannak D. Effects of valproic acid, carbamazepine and phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia 44 (2003) 708-711
13. Cengiz M., Yuksel A., and Seven M. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol. Res. 41 (2000) 423-425
14. Gao X., Margolis R., Leeds P., Hough C., Post R., and Chuang D. Carbamazepine induction of apoptosis in cultured cerebellar neurons: effects of N-methyl-d-aspartate, aurintricarboxylic acid and cycloheximide. Brain Res. 703 (1995) 63-71
15. Pavone A., and Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 44 (2003) 34-39
16. Araujo I.M., Ambrosio A.F., Leal E.C., Verdasca M.J., Malva J.O., Soares-da-Silva P., Carvalho A.P., and Carvalho C.M. Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093. Epilepsia 45 (2004) 1498-1505
17. Awara W., El-Gohary M., El-Nabi S., and Fadel W. In vivo and in vitro evaluation of the mutagenic potential of carbamazepine: does melatonin have anti-mutagenic activity?. Toxicology 125 (1998) 45-52
18. Suwalsky M., Mennickent S., Norris B., Villena F., and Sotomayor C. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol. in Vitro 20 (2006) 1363-1369
19. Jos A., Repetto G., Ríos J., Hazen M., Molero M., del Peso A., Salguero M., Fernández Freire P., and Pérez Martín J. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicol. in Vitro 17 (2003) 525-532
20. Tittle T., and Schaumann B. Effects of antiepileptic drugs on growth of murine lymphoid tumor cells in single-cell culture. Epilepsia 33 (1992) 729-735
21. Stander M., Dichgans J., and Weller M. Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glima cells. J. Neurooncol. 37 (1998) 191-198
22. Feldkamp J., Becker A., Witte O., Scharff D., and Scherbaum W. Long-term anticonvulsant therapy leads to low bone mineral density-evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Exp. Clin. Endocrinol. Diabetes 108 (2000) 37-43
23. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
24. Haggarty S., Mayer T., Miyamoto D., Fathi R., King R., Mitchinson T., and Schreiber S. Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem. Biol. 7 (2000) 275-286
25. Jordan M., and Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4 (2004) 253-265
26. Mitchison T., Evans L., Schulze E., and Kirschner M. Sites of microtubule assembly and disassembly in the mitotic spindle. Cell 23 (1986) 515-527
27. Karsenti E., and Vernos I. The mitotic spindle, a self-made machine. Science 294 (2001) 543-547
28. Sharp D., Rogers G., and Scholey J. Microtubule motors in mitosis. Nature 407 (2000) 41-47
29. Wittmann T., Hyman A., and Desai A. The spindle: a dynamic assembly of microtubules and motors. Nat. Cell Biol. 3 (2001) E28-E34
30. Correia J., and Lobert S. Physicochemical aspects of tubulin-interacting antimitotic drugs. Curr. Pharm. Des. 7 (2001) 1213-1228
31. Bacher G., Beckers T., Emig P., Klenner T., Kutscher B., and Nicker B. New small-molecule tubulin inhibitors. Pure Appl. Chem. 73 (2001) 1459-1464
32. Jordan M. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anti-Cancer Agents 2 (2002) 1-7
33. Zhou J., Yao J., and Joshi H. Attachment and tension in the spindle assembly checkpoint. J. Cell Sci. 115 (2002) 3547-3555
34. Chen J., and Horwitz S. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res. 62 (2002) 1935-1938
35. Mountain V., and Compton D. Dissecting the role of molecular motors in the mitotic spindle. Anat. Rec. 261 (2000) 14-24
36. Andrews P., Knatko E., Moore W., and Swedlow J. Mitotic mechanics: the auroras come into view. Curr. Opin. Cell Biol. 15 (2003) 672-683
37. Barr F., Sillje H., and Nigg E. Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 5 (2004) 429-440
38. Bhalla K. Microtubule-targeted anticancer agents and apoptosis. Oncogene 22 (2003) 9075-9086
39. Mollinedo F., and Gajate C. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8 (2003) 413-450
40. Zhou J., and Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr. Med. Chem. Anti-Cancer Agents 5 (2005) 65-71
41. Tao W., South V., Zhang Y., Davide J., Farrel L., Kohl N., Sepp-Lorenzino L., and Lobell R. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8 (2005) 49-59
42. Gizatullin F., Yao Y., Kung V., Harding M., Loda M., and Shapiro G. The aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res. 66 (2006) 7668-7677
43. Lansing T., McConnell R., Duckett D., Spehar G., Knick V., Hassler D., Noro N., Furuta M., Emmitte K., Gilmer T., Mook T.J., and Cheung M. In vitro biological activity of novel small-molecule inhibitor of polo-like kinase 1. Mol. Cancer Ther. 6 (2007) 450-459
44. Waters J., Cole R., and Rieder C. The force-producing mechanism for centrosome separation during spindle formation in vertebrates is intrinsic to each aster. J. Cell Biol. 122 (1993) 361-372
45. Heck M., Pereira A., Pesavento P., Yannoni Y., Spradling A., and Goldstein L. The kinesin-like protein KLP61F is essential for mitosis in Drosophila. J. Cell Biol. 123 (1993) 665-679
46. Sluder G., Miller F., and Rieder C. Reproductive capacity of sea urchin centrosomes without centrioles. Cell Motil. Cytoskeleton 13 (1989) 264-273
47. Winey M., Goetsch L., Baum P., and Byers B. MSP1 and MSP2: novel yeast genes defining distinct steps of spindle pole body duplication. J. Cell Biol. 114 (1991) 745-754
48. Thrower D., Jordan M., and Wilson L. Modulation of CENP-E organization at kinetochores by spindle microtubule attachment. Cell Motil. Cytoskeleton 35 (1996) 121-133
49. Andersson L., Lehto V.-P., Stenman S., Badley R., and Virtanen I. Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar separation. Nature 291 (1981) 247-248
50. Lafi A., Parry E., and Parry J. The effects of benzodiazepines upon the fidelity of mitotic cell division in cultured Chinese hamster cells. Mutat. Res. 189 (1987) 319-332
51. Gassner P., and Adler I. Analysis of chemically induced spindle aberrations in male mouse germ cells: comparison of differential and immunofluorescent staining procedures. Mutagenesis 10 (1995) 243-252
52. Vitale I., Antoccia A., Crateri P., Leone S., Arancia G., and Tanzarella C. Caspase-independent apoptosis is activated by diazepam-induced mitotic failure in HeLa cells, but not in human primary fibroblasts. Apoptosis 10 (2005) 909-920
53. Blangy A., Lane H., d'Herin P., Harper M., Kress M., and Nigg E. Phosphorylation by p34 cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83 (1995) 1159-1169
54. Sawin K., and Mitchinson T. Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4289-4293
55. Mayer T., Kapoor T., Haggarty S., King R., Schreiber S., and Mitchison T. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286 (1999) 971-974
56. Kapoor T., Mayer T., Coughlin M., and Mitchison T. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J. Cell Biol. 150 (2000) 975-988
57. Sakowicz R., Finer J., Beraud C., Crompton A., Lewis E., Fritsch A., Lee Y., Mak J., Moody R., Turincio R., Chabala J., Gonzales P., Roth S., Weitman S., and Wood K. Antitumor activity of a kinesin inhibitor. Cancer Res. 64 (2004) 3276-3280
58. Marcus A., Peters U., Thomas S., Garrett S., Zelnak A., Kapoor T., and Giannakakou P. Mitotic kinesin inhibitors induce mitotic arrest and cell death in taxol-resistant and -sensitive cancer cells. J. Biol. Chem. (2005)
59. Sunder-Plassman N., Sarli V., Gartner M., Utz M., Seiler J., Huemmer S., Mayer T., Surrey T., and Gianni A. Synthesis and biological evaluation of new tetrahydro-β-carbolines as inhibitors of the mitotic kinesin Eg5. Bioorg. Med. Chem. 13 (2005) 6094-6111
60. Lutz W., Lingle W., McCormick D., Greenwood T., and Salisbury J. Phosphorylation of centrin during the cell cycle and its role in centriole separation preceding centrosome duplication. J. Biol. Chem. 276 (2001) 20774-20780
61. Diviani D., Langeberg L., Doxey S., and Scott J. Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain. Curr. Biol. 10 (2000) 417-420
62. Jensen J., and Mork A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur. Neuropsychopharmacol. 7 (1997) 173-179
63. Chen G., Hasanat K., Bechuk J., Moore G., Glitz D., and Manji H. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom. Med. 61 (1999) 599-617
64. Giet R., and Prigent C. The Xenopus laevis aurora/Ip11p-related kinase pEg2 participates in the stability of the bipolar mitotic spindle. Exp. Cell Res. 258 (2000) 145-151
65. Sumara I., Gimenez-Abian J., Gerlich D., Hirota T., Kraft C., de la Torre C., Ellenberg J., and Peters J. Roles of polo-like kinase 1 in the assembly of functional mitotic splindles. Curr. Biol. 14 (2004) 1712-1722
66. Jordan M., Wendell K., Gardiner S., Derry W., Copp H., and Wilson L. Mitotic block induced in HeLa cells by low concentration of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56 (1996) 816-825
67. Wang T., Wang H., and Soong Y. Paclitaxel-induced cell death. Where the cell cycle and apoptosis come together. Cancer 88 (2000) 2619-2628